ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

Trials Approved In October

December 28, 2001

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators

October 3, 2014